TH160649A - Machines and methods for pharmacokinetic dosing requirements - Google Patents

Abstract

Revised Summary of Invention 11/03/2016 Systems and Methods for Providing Therapeutic Plasma Protein Dosage Requirements, Including Patient Pharmacokinetic Profile Determination. Using the Bayesian model of a patient's pharmacokinetic profile, the system and sample method were also included in determining the first dose dosing requirements. For a specific first dose range, which includes (i) the first dose and (ii) the therapeutic plasma protein level in the patient. Over a period of time, based at least on the pharmacokinetic profile. And determining Second dose requirements For a specific second dose interval, which includes (i) a second dose and (ii) the level of the second therapeutic plasma protein in the patient over the entire period of time, on a minimum basis on: The system and method pharmacokinetic profile is further included, as well as a display of the first dose requirements. And the provision of Second dose On the client device until the first dosing requirements are met Show results in conjunction with the second dosing requirements. -------------------------------------------------- ---------------------- Systems and methods for establishing therapeutic plasma protein size models include: Determine the pharmacokinetic profile of the patient using the Bayesian model of the clinical profile. Example of patient pharmacokinetics The sample system and method also includes determining the size format. First, for a specific dosing frequency, which includes (i) first dose and (ii) first therapeutic plasma protein level in the patient over a period of time is based on at least the clinical profile. Pharmacokinetics and determination of the second dose variation for the second specific dosing frequency including (i) the second dose and (ii) the second therapeutic plasma protein level in the patient over time. That are based on at least a pharmacokinetic profile Examples of systems and methods include additional The first dose format and the second form format are displayed on the client device so that the first dose format is displayed in association with the second dose pattern.

Claims (1)

: Revised invention summary 11/03/2016 Systems and methods for establishing therapeutic plasma protein dosing requirements, including determining a patient's pharmacokinetic profile. Using the Bayesian model of a patient's pharmacokinetic profile, the system and sample method were also included in determining the first dose dosing requirements. For a specific first dose range, which includes (i) the first dose and (ii) the therapeutic plasma protein level in the patient. Over a period of time, based at least on the pharmacokinetic profile. And determining Second dose requirements For a specific second dose interval, which includes (i) a second dose and (ii) the level of the second therapeutic plasma protein in the patient over the entire period of time, on a minimum basis on: The system and method pharmacokinetic profile is further included, as well as a display of the first dose requirements. And the provision of Second dose On the client device until the first dosing requirements are met Show results in conjunction with the second dosing requirements. -------------------------------------------------- ---------------------- Systems and methods for establishing therapeutic plasma protein size models include: Determine the pharmacokinetic profile of the patient using the Bayesian model of the clinical profile. Example of patient pharmacokinetics The sample system and method also includes determining the size format. First, for a specific dosing frequency, which includes (i) first dose and (ii) first therapeutic plasma protein level in the patient over a period of time is based on at least the clinical profile. Pharmacokinetics and determination of the second dose variation for the second specific dosing frequency including (i) the second dose and (ii) the second therapeutic plasma protein level in the patient over time. That are based on at least a pharmacokinetic profile Examples of systems and methods include additional Displaying the first size format and the second size format on the client device so that the first size format is displayed in association with the second size format. (Item one) which will appear on the advertisement page: edit 11/03/2016 1. Methods for establishing therapeutic plasma protein dosing dose models, including: determination, via a processor, estimated pharmacokinetic profile of the patient by Using a Bayesian model of a pharmacokinetic profile of a patient at As an example, an estimated pharmacokinetic profile is based on at least one patient's body weight or age. Tag: drug patents.